...
机译:患者报告的可耐受性和可接受性1 rilpivirine长效注射HIV-1感染:随机Latte-2研究结果为96周
Healthcare, London, UK;
2Hospital Universitario 12 de Octubre, UCM, (imas12), Madrid, Spain;
Anti-Retroviral Agents; Rilpivirine; HIVPatient Reported OutcomesInjectablesSatisfactionrepair cycle;